Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease

International Journal of Developmental Neuroscience

Volumn 21, Issue 6, 2003, Pages 327-332

  Bridi, Raquel ^a   Araldi, Janaína ^a   Sgarbi, Miriam B ^a   Testa, Carla G ^a   Durigon, Karina ^a   Wajner, Moacir ^a   Dutra Filho, Carlos Severo ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antioxidant brain defenses; Free radicals; Isoleucine; Leucine; Maple syrup urine disease; Oxidative stress; Valine

Indexed keywords

AMINO ACID; BRANCHED CHAIN AMINO ACID; FREE RADICAL; ISOLEUCINE; LEUCINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN; BRAIN CORTEX; CHEMOLUMINESCENCE; CONTROLLED STUDY; IN VITRO STUDY; LIPID PEROXIDATION; MALE; MAPLE SYRUP URINE DISEASE; METABOLITE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ACER;

EID: 0042122354     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(03)00074-1     Document Type: Article

References (42)

1. Araújo P., Wassermann G.F., Tallini K., Furlanetto V., Vargas C.R., Wannmacher C.M.D., Dutra-Filho C.S., Wyse A.T.S., Wajner M. Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats. Neurochem. Int. 38:2001;529-537.
2. Bremer, H.J., Duran, M., Kamerling, J.P., Przyrembel, H., Wadman, S.K., 1981. Disturbances of Amino Acid Metabolism: Clinical Chemistry and Diagnosis. Urban & Schaqarzenberg, Baltimore, pp. 359-363.
3. Chuang, D.T., Shih, V.E., 2001. Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver, C.R., Beaudet, A.L., Sly, W.L., Valle, D. (Eds.), The Metabolic and Molecular Bases of Inherited Disease, eighth ed. McGraw-Hill, New York, pp. 1971-2005.
4. Cini M., Fariello R.G., Bianchetti A., Moretti A. Studies on lipid peroxidation in the rat brain. Neurochem. Res. 19:1994;283-288.
5. Danbold N.C. Glutamate uptake. Prog. Neurobiol. 65:2001;1-105.
6. Danner, D.J., Elsas II, L.J., 1989. Disorders of branched chain amino acid and keto acid metabolism. In: Scriver, C.R., Beaudet, A.L., Sly, W.L., Valle, D. (Eds.), The Metabolic Basis of Inherited Disease, sixth ed. McGraw-Hill, New York, pp. 671-692.
7. Dodd P.R., Wiliams A.L., Gundlach A.L., Harper P.A.W., Healy P.J., Dennis J.A., Johnston G.A.R. Glutamate and γ-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves. J. Neurochem. 59:1992;582-590.
8. Esterbauer H., Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186:1990;407-421.
9. Evelson P., Travacio M., Repetto M., Escobar J., Llesuy S., Lissi E.A. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch. Biochem. Biophys. 388:2001;261-266.
10. Fontella F.U., Gassen E., Pulrolnik V., Wannmacher C.M.D., Klein A.B., Wajner M., Dutra C.S. Stimulation of lipid peroxidation in vitro in rat brain by metabolites accumulating in maple syrup urine disease. Metab. Brain Dis. 17:2002;47-54.
11. González-Flecha B., Llesuy S., Boveris A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver and muscle. Free Radic. Biol. Med. 10:1991;93-100.
12. Halestrap A.P., Brand M.D., Denton R.M. Inhibition of mitochondrial pyruvate transport by phenylpyruvate and α-ketoisocaproate. Biochim. Biophys. Acta. 367:1974;102-108.
13. Halliwell B. Role of free radicals in the neurodegenerative diseases. Drugs Aging. 18:2001;685-716.
14. Halliwell, B., Gutteridge, J.M.C., 2001a. Detection of free radicals and others reactive species: trapping and fingerprinting. In: Halliwell, B., Gutteridge, J.M.C. (Eds.), Free Radicals in Biology and Medicine. Oxford University Press, Oxford, pp. 351-425.
15. Halliwell, B., Gutteridge, J.M.C., 2001b. Antioxidant defences. In: Halliwell, B., Gutteridge, J.M.C. (Eds.), Free Radicals in Biology and Medicine. Oxford University Press, Oxford, pp. 105-245.
16. Howell R.K., Lee M. Influence of α-ketoacids on the respiration of brain in vitro. Proc. Soc. Exp. Biol. Med. 113:1963;660-663.
17. Janero D.R. Malondilaldehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med. 9:1990;515-540.
18. Jouvet P., Rustin P., Taylor D.L., Pocock J.M., Felderhoff-Mueser U., Mazarakis N.D., Sarraf C., Joashi U., Koszma M., Greewood K., Edwards A.D., Mehmet H. Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane despolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol. Biol. Cell. 11:2000;1919-1932.
19. Land J.M., Mowbray J., Clark J.B. Control of pyruvate and β-hydroxybutyrate utilization in rat brain mitochondria and its relevance to phenylketonuria and maple syrup urine disease. J. Neurochem. 26:1976;823-830.
20. Lissi E., Pascual C., Del Castillo M.D. Luminol luminescence induced by 2,2′-azo-bis-(2-amidinopropane) thermolysis. Free Radic. Res. Commun. 17:1992;299-311.
21. Lissi E., Salim-Hanna M., Pascual C., Del Castillo M.D. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic. Biol. Med. 18:1995;153-158.
22. Llesuy S.F., Milei J., Molina H., Boveris A., Milei S. Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4′-epiadriamycin in mice. Tumori. 71:1985;241-249.
23. Llesuy S.F., Evelson P., Gonzalez-Flecha B., Peralta J., Carreras M.C., Poderoso J.J., Boveris A. Oxidative stress in muscle and liver of rats with septic syndrome. Free Radic. Biol. Med. 16:1994;445-451.
24. Lowry O.H., Rosebrough N.J., Lewis-Farr A., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
25. Meneghini, R., Martins, E.L., 1993. Hydrogen peroxide and DNA damage. In: Halliwell, B., Arnoma, O.I. (Eds.), DNA and Free Radicals. Ellis Horwood, UK, pp. 83-144.
26. Nyhan, W.L., 1984. Abnormalities in Amino Acid Metabolism in Clinical Medicine. Appleton-Century-Crofts, Norwalk, pp. 21-35.
27. Peinemann F., Danner D.J. Maple syrup urine disease 1954 to 1993. J. Inherit. Metab. Dis. 17:1994;3-15.
28. Pilla C., Cardozo R.F.D., Dutra C.S., Wyze A.T.S., Wajner M., Wannmacher C.M.D. Effect of leucine administration on creatine kinase activity in rat brain. Metab. Brain Dis. 18:2003;17-25.
29. Prensky A.L., Moser H.W. Changes in the amino acid composition of proteolipids of white matter during maturation of the human nervous system. J. Neurochem. 14:1967;117-121.
30. A-gated chloride channel by reactive oxygen species. J. Neurochem. 80:2002;383-391.
31. Saudubray, J.M., Ogier, H., Billette de Vilmeur, T., Bonnefont, J.P., Lyonnet, S., Herve, F., Munnich, A., Rabier, D., Coude, M., Charpentier, C., 1991. Inborn errors of the metabolism of branched-chain amino acids. In: Schuab, J., van Hoof, F., Vis, H.L. (Eds.), Inborn Errors of Metabolism. Raven, New York, pp. 137-153.
32. Schadewaldt P., Wendel U. Metabolism of branched-chain amino acids in maple syrup urine disease. Eur. J. Pediatr. 156(Suppl. 1):1997;S62-S66.
33. Snyderman S.E., Norton P.M., Roitman E. Maple syrup urine disease with particular reference to diet therapy. Pediatrics. 34:1964;454-472.
34. Snyderman S.E., Goldstein F., Sansaricq C., Norton P.M. The relationship between the branched chain amino acids and their γ-ketoacids in maple syrup urine disease. Pediatr. Res. 18:1984;851-853.
35. Taketomi T., Kunishita T., Hara A., Mizushima S. Abnormal protein and lipid compositions of the cerebral myelin of a patient with maple syrup urine disease. Jpn. J. Exp. Med. 53:1983;109-116.
36. Tashian R.E. Inhibition of brain glutamic acid decarboxylase by phenylalanine, valine, and leucine derivatives: a suggestion concerning the etiology of the neurological defect in phenylketonuria and branched-chain ketonuria. Metabolism. 10:1961;393-402.
37. Tavares R.G., Santos C.E.S., Tasca C., Wajner M., Souza D.O., Dutra-Filho C.S. Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease. J. Neurol. Sci. 181:2000;44-49.
38. Treacy E., Clow C.L., Reade T.R., Chitayat D., Mamer O.A., Scriver C.R. Maple syrup urine disease: interrelationship between branched chain amino-, oxo-, and hydroxyacids implications for treatment association with CNS dysmelination. J. Inherit. Metab. Dis. 15:1992;121-135.
39. Tribble D., Shapira R. Myelin proteins: degradation in rat brain initiated by metabolites causative of maple syrup urine disease. Biochem. Biophys. Res. Commun. 114:1983;440-446.
40. Yeman S.J. The mammalian 2-oxoacid dehydrogenase: a complex family. Trends Biochem. Sci. 11:1986;293-296.
41. Yuwiler A., Geller E. Serotonin depletion by dietary leucine. Nature. 208:1965;83-84.
42. Zielke H.R., Huang Y., Tildon J.T., Zielke C.L., Baab P.J. Elevation of amino acids in the interstitial space of the rat brain following infusion of large neutral amino and keto acids by microdialysis: leucine infusion. Dev. Neurosci. 18:1996;420-425.